<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> is a <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">neurocutaneous syndrome</z:e> that includes facial and leptomeningeal <z:mp ids='MP_0002947'>angiomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Imaging findings include cerebral lobar <z:mpath ids='MPATH_127'>atrophy</z:mpath>, <z:hpo ids='HP_0002514'>brain calcifications</z:hpo>, choroid plexus enlargement, cranial diploÃ« prominence, and <z:hpo ids='HP_0002624'>venous abnormalities</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We compared the efficacy of CT and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging in making the diagnosis in 14 consecutive patients </plain></SENT>
<SENT sid="3" pm="."><plain>CT, with and without contrast enhancement, was performed in <z:hpo ids='HP_0000001'>all</z:hpo> patients, and 11 of the 14 had <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging (eight before and after administration of IV <z:chebi fb="0" ids="31797">gadopentetate dimeglumine</z:chebi>) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging was better than CT in showing the extent and degree of brain parenchymal <z:mpath ids='MPATH_127'>atrophy</z:mpath>, the presumed ischemic changes affecting the gray and white matter, and the cranial diploetic prominence on the affected side </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging after contrast administration permitted a better evaluation of the extent and patency of the leptomeningeal angiomatous malformation and the parenchymal venous anomalies </plain></SENT>
<SENT sid="6" pm="."><plain>CT was better than <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging in showing the presence and extent of cortical calcifications </plain></SENT>
<SENT sid="7" pm="."><plain>Enhanced CT and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging were equal in evaluating the prominence of the ipsilateral choroid plexus </plain></SENT>
<SENT sid="8" pm="."><plain>Our experience indicates that contrast-enhanced <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> imaging is the method of choice in the diagnosis of <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Unenhanced CT should be used only if <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> findings are <z:mpath ids='MPATH_458'>normal</z:mpath>, to exclude the presence of <z:hpo ids='HP_0002514'>intracranial calcifications</z:hpo> </plain></SENT>
</text></document>